vTv Therapeutics Inc.

VTVT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$22,705-$20,250-$19,164-$17,731
Dep. & Amort.$89$90$92$89
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,757$1,578$0$2,356
Change in WC-$5,438$4,394$5,385$35
Other Non-Cash-$10-$4,893-$1,559-$4,057
Operating Cash Flow-$25,307-$19,081-$15,246-$19,308
Investing Activities
PP&E Inv.$0$0-$21$0
Net Acquisitions$0$4,404$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$4,404$0$0
Other Inv. Act.$0-$4,404$0$0
Investing Cash Flow$0$4,404-$21$0
Financing Activities
Debt Repay.-$191-$33-$808$172
Stock Issued$52,798$12,030$14,786$26,757
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$47
Financing Cash Flow$52,607$11,997$13,978$26,976
Forex Effect$0$0$0$0
Net Chg. in Cash$27,300-$2,680-$1,289$7,668
Supplemental Information
Beg. Cash$9,446$12,126$13,415$5,747
End Cash$36,746$9,446$12,126$13,415
Free Cash Flow-$25,307-$19,081-$15,267-$19,308
vTv Therapeutics Inc. (VTVT) Financial Statements & Key Stats | AlphaPilot